Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-02

Clinical Trial Update: Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting on efficacy and safety of Fosrenol for elevated serum phosphate in adults with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSRENOL (lanthanum carbonate)

Snippet

Sponsor: Shire | Conditions: Kidney Failure, Chronic | Phase 4 | Status: COMPLETED